ArticleCancer cell international2025

Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy.

Verena Schweihofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.